Allogeneic BMT versus autologous BMT in childhood acute lymphoblastic leukemia (ALL): an Italian cooperative study of vincristine (VCR), F-TBI and cyclophosphamide. AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) Italy

Bone Marrow Transplant. 1991:7 Suppl 2:132.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation / methods*
  • Bone Marrow Transplantation / mortality
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use*
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Infant
  • Italy / epidemiology
  • Male
  • Neoplasm Recurrence, Local / epidemiology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
  • Remission Induction
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Vincristine / administration & dosage
  • Vincristine / adverse effects
  • Vincristine / therapeutic use*
  • Whole-Body Irradiation* / adverse effects

Substances

  • Vincristine
  • Cyclophosphamide